NASDAQ:XELA - Exela Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.03
▼ -0.03 (-1.46%)
1 month | 3 months | 12 months
Get New Exela Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XELA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XELA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Exela Technologies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.03.
Buy
The current consensus among 1 investment analysts is to buy stock in Exela Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/22/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/13/2020Cantor FitzgeraldReiterated RatingOverweightLow
i
Rating by P. Zuanic at Cantor Fitzgerald
6/8/2020Cantor FitzgeraldReiterated RatingOverweightHigh
i
Rating by D. Kootman at Cantor Fitzgerald
8/9/2019Royal Bank of CanadaSet Price TargetBuy$12.00Medium
i
Rating by Daniel Perlin at Royal Bank of Canada
8/9/2019Nomura SecuritiesLower Price TargetBuy$24.00 ➝ $15.00High
i
3/19/2019Cantor FitzgeraldReiterated RatingBuy$27.00High
i
1/16/2019Morgan StanleyDowngradeOverweight ➝ Equal WeightMedium
i
Rating by Brian Essex at Morgan Stanley
10/22/2018Morgan StanleyInitiated CoverageOverweight ➝ Overweight$27.00High
i
8/12/2018Nomura SecuritiesReiterated RatingBuy$30.00Medium
i
7/30/2018Nomura SecuritiesInitiated CoverageBuy$30.00High
i
6/24/2018Cantor FitzgeraldReiterated RatingBuy$27.00Medium
i
4/10/2018Cantor FitzgeraldReiterated RatingBuy$27.00High
i
Rating by J. Foresi at Cantor Fitzgerald
12/17/2017Cantor FitzgeraldReiterated RatingBuy$27.00Low
i
Rating by J. Foresi at Cantor Fitzgerald
12/5/2017Cantor FitzgeraldInitiated CoverageOverweight$27.00High
i
Rating by J. Foresi at Cantor Fitzgerald
(Data available from 4/14/2016 forward)
Exela Technologies logo
Exela Technologies, Inc. (Exela), formerly Quinpario Acquisition Corp. 2, is engaged in providing information and transaction processing solutions. The Company’s segments include Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS) and Legal & Loss Prevention Services (LLPS). ITPS provides industry solutions for banking and financial services, including lending solutions for mortgages, banking solutions for clearing, anti-money laundering, sanctions, cross-border settlement; property and casualty insurance solutions for enrollments, and communications. The HS segment offerings include integrated accounts payable and accounts receivable, and information management for both the healthcare payer and provider markets. The LLPS segment solutions include processing of legal claims for class action and mass action settlement administrations, involving project management support, notification and collection, analysis, and distribution of settlement funds.
Read More

Today's Range

Now: $2.03
$2.00
$2.08

50 Day Range

MA: $2.51
$1.61
$4.61

52 Week Range

Now: $2.03
$0.51
$7.82

Volume

730,477 shs

Average Volume

13,181,579 shs

Market Capitalization

$119.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Exela Technologies?

The following Wall Street research analysts have issued research reports on Exela Technologies in the last twelve months: Cantor Fitzgerald, and Zacks Investment Research.
View the latest analyst ratings for XELA.

What is the current price target for Exela Technologies?

0 Wall Street analysts have set twelve-month price targets for Exela Technologies in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Exela Technologies in the next year.
View the latest price targets for XELA.

What is the current consensus analyst rating for Exela Technologies?

Exela Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe XELA will outperform the market and that investors should add to their positions of Exela Technologies.
View the latest ratings for XELA.

What other companies compete with Exela Technologies?

How do I contact Exela Technologies' investor relations team?

Exela Technologies' physical mailing address is 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061. The company's listed phone number is 844-935-2832 and its investor relations email address is [email protected] The official website for Exela Technologies is www.exelatech.com.